Novasyte is honored to announce that we ranked 1,692 overall and 125 in the healthcare category on the 2018 Inc. 5000 List of Fastest-Growing Private Companies in America. This marks the sixth consecutive year achieving this recognition, putting us on an exclusive short list of only six percent of companies acknowledged for maintaining this level of continued growth over the years, including Microsoft, Timberland, Vizio, Intuit, Chobani, Oracle and Zappos.com.
Recent Posts
Novasyte Recognized Among Only Six Percent of Companies Making the Inc. 5000 List for Six Consecutive Years
Topics: Novasyte News, Business Awards, Novasyte Growth, Leadership News, Medical Device Industry, San Diego, CA, Pharmaceutical Industry
Retirement Cliff Puts Field Service Operations At Risk
The MedTech Tndustry is no stranger to change.
Increasing customer demands coupled with reduced budgets, higher targets and new technologies are requiring organizations to think differently and pivot seamlessly — all while balancing risk.
A new challenge the MedTech industry is facing is how to plan for the aging workforce crisis among field service engineers.
Topics: Field Technical
Pressures Mount for Drug Manufacturers to Reduce Cost, Forcing Reevaluation of SG&A Costs and Commercial Models
Pharmaceutical manufacturers today are facing increasing pressures from The Trump Administration to reduce the cost of drug prices.
Announced on Wednesday of this week, Novartis indicated they would not be raising prices on its products for the remainder of 2018.1 They are joining Pfizer, whose chief executive officer, Ian Read, announced on July 10 that the company would delay increasing the prices on dozens of drug products until 2019, following President Trump publicly spotlighting the firm the day prior.2
This follows the initial statement from The Trump Administration in May 2018 regarding a comprehensive blueprint strategy to lower drug prices.
Topics: Industry Trends, Pharmaceutical Industry
MedTech Industry Trend: The Shift Towards a Centralized Decision-Making Process
For many medtech manufacturers, commercializing products into a new healthcare facility brings a series of opportunities and challenges, including:
- The need to provide proof of product efficacy and cost effectiveness,
- The need to deliver new product into the facility quickly,
- The need to align with facility leadership on the strategic direction to implement, and
- The need to train the facility’s end-users to support adoption.
Topics: Medical Device Recall Help, Med-Tech Industry Update, Medical Device Industry, Industry Trends, Industry Advancements, SMART recall program, White Paper
FDA Confirms Third-Party Entities Provide High Quality, Safe and Effective Servicing of Medical Devices
In May 2018, the FDA released a report titled "FDA Report on the Quality, Safety and Effectiveness of Servicing of Medical Devices," issued by the Secretary of Health and Human Services and in accordance with The Food and Drug Administration Reauthorization Act (FDARA). The FDA examined product servicing by manufacturers, healthcare establishments and third-party providers who refurbish, recondition, rebuild, remarket, service and repair medical devices.
Topics: Med-Tech Industry Update, Quality Management System, Medical Device Industry, Medical Device Field Action, San Diego, CA, Industry Trends, ISO Certification, Industry Advancements, Field Technical
Novasyte Achieves Ongoing "World Class" Client Satisfaction
The importance of providing and fearlessly seeking feedback at Novasyte goes back to the Company's inception in 2008. This cultural priority is not simply a theory discussed at the annual company meeting, but a living, breathing, organically-developed reality of the day-to-day environment that allows for cross-departmental synergies to develop, relationships to grow, and issues to be resolved in real-time.
Topics: Novasyte News, Med-Tech Industry Update, Quality Management System, San Diego, CA, Industry Trends, ISO Certification
EY Announces Tim Gleeson of Novasyte Entrepreneur Of The Year 2018 Award Finalist in San Diego
EY today announced that Tim Gleeson, Chairman and CEO of Novasyte, is a finalist for the Entrepreneur Of The Year® 2018 Award in San Diego.
The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala event on June 7, 2018 at the Fairmont Grand Del Mar.
Topics: Novasyte News, Novasyte Growth, Leadership News, Med-Tech Industry Update, Employee Classification, Medical Device Industry, San Diego, CA
Tim Gleeson Earns Semifinalist Nomination for the EY Entrepreneur Of The Year 2018 San Diego Regional Award
Novasyte is excited to announce that Tim Gleeson, Chairman and CEO, has been selected as a semi-finalist in the Ernst & Young Entrepreneur Of The Year 2018 San Diego Regional Awards program.
Topics: Novasyte News, Novasyte Growth, Leadership News, Med-Tech Industry Update, Employee Classification, Medical Device Industry, San Diego, CA
This weekend marks the start of Advamed's CEO Summit here in San Diego, California, and Novayste is excited to announce our sponsorship of the event.
Bringing together many of the greatest minds and executive-level leaders in the med-tech industry, the CEO Summit facilitates engaging discussions around the global outlook and evolving trends taking place in the healthcare industry.
Topics: Novasyte News, Novasyte Partnership, Medical Device Industry, San Diego, CA
February marks Novasyte's 10 year company anniversary. As we reflect on where we started and how far we have come as an organization, we wanted to express thanks to every client, team member and vendor who has helped shape us as an organization.
Topics: Novasyte News, Novasyte Growth, San Diego, CA